Figure 10

Change in number of colorectal polyps in FAP patients receiving placebo or celecoxib (Celebrex^R) for 6 months. The reduction in polyp burden, versus placebo, was significant (*P = 0.003) with the dosage of 400 mg twice a day (data for figure derived from reference [107]).